These are the books I study for pharmacology exams Within one month my yearly examination are going to be start i will ask you last year question you need to answer all the question from these two books only ok
python3 -c " from pypdf import PdfReader import os # Check both files files = { 'Vet Pharmacology': '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Essentials_Vet_Pharmacology_under20MB.pdf', 'Flashcards': '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' } for name, path in files.items(): reader = PdfReader(path) pages = len(reader.pages) # Extract first page text sample sample = reader.pages[0].extract_text()[:500] if reader.pages else 'No text' print(f'=== {name} ===') print(f'Pages: {pages}') print(f'First page sample: {sample[:300]}') print() "
python3 -c " import pdfplumber files = { 'Vet Pharmacology': '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Essentials_Vet_Pharmacology_under20MB.pdf', 'Flashcards': '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' } for name, path in files.items(): with pdfplumber.open(path) as pdf: print(f'=== {name} === ({len(pdf.pages)} pages)') # Try pages 1, 5, 10 for i in [0, 1, 2, 5, 10]: if i < len(pdf.pages): text = pdf.pages[i].extract_text() if text and text.strip(): print(f' Page {i+1}: {text[:300]}') break else: print(' No extractable text found in sampled pages') print() "
python3 -c " import pdfplumber path = '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' with pdfplumber.open(path) as pdf: print(f'Total pages: {len(pdf.pages)}') # Extract table of contents / first 20 pages to understand structure for i in range(2, 25): text = pdf.pages[i].extract_text() if text and text.strip(): print(f'--- Page {i+1} ---') print(text[:400]) print() " 2>&1 | head -150
Good
What is pharmacopoeia and tell me about Indian pharmacopoeia
python3 -c " import pdfplumber path = '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' with pdfplumber.open(path) as pdf: for i, page in enumerate(pdf.pages): text = page.extract_text() if text and ('pharmacopoeia' in text.lower() or 'pharmacopeia' in text.lower() or 'indian' in text.lower()): print(f'--- Page {i+1} ---') print(text[:600]) print() "
| Feature | Details |
|---|---|
| Published by | Indian Pharmacopoeia Commission (IPC), Ghaziabad |
| Under authority of | Ministry of Health & Family Welfare, Government of India |
| Legal authority | Drugs and Cosmetics Act, 1940 |
| First edition | 1955 |
| Latest edition | IP 2022 (8th edition) |
| Symbol | IP (printed after the drug name, e.g., Paracetamol IP) |
| Name | Country | Abbreviation |
|---|---|---|
| British Pharmacopoeia | UK | BP |
| United States Pharmacopeia | USA | USP |
| European Pharmacopoeia | Europe | EP/Ph.Eur. |
| International Pharmacopoeia | WHO | Ph.Int. |
| Veterinary Pharmacopoeia | India | IVP (Indian Veterinary Pharmacopoeia) |
Advantages for inhalation route of drug administration
python3 -c " import pdfplumber path = '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' with pdfplumber.open(path) as pdf: for i, page in enumerate(pdf.pages): text = page.extract_text() if text and ('inhal' in text.lower() or 'route' in text.lower() or 'administration' in text.lower()): print(f'--- Page {i+1} ---') print(text[:800]) print() " 2>&1 | head -100
| Advantage | Reason |
|---|---|
| Rapid onset | Large alveolar surface + rich blood supply |
| Local action | Drug delivered directly to lung tissue |
| No first-pass effect | Bypasses hepatic portal system |
| Easy self-use | MDIs, nebulizers available |
| Non-invasive | No injection needed |
| Dose titration | Inhaled concentration adjustable in real time |
| Only route for gases | Volatile anesthetics can only be given this way |
Why bio transformation of drugs and chemical occur in our body
python3 -c " import pdfplumber path = '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' with pdfplumber.open(path) as pdf: for i, page in enumerate(pdf.pages): text = page.extract_text() if text and ('biotransform' in text.lower() or 'metabolism' in text.lower() or 'metabolize' in text.lower() or 'first pass' in text.lower()): print(f'--- Page {i+1} ---') print(text[:800]) print() " 2>&1 | head -120
| Site | Importance |
|---|---|
| Liver | Primary and most important site (richest in CYP450 enzymes) |
| Intestinal wall | First-pass metabolism for oral drugs |
| Kidneys | Some renal metabolism |
| Lungs | Metabolism of inhaled drugs |
| Plasma | Esterases break down some drugs (e.g., succinylcholine) |
| Skin | Topical drug metabolism |
| Reason | Outcome |
|---|---|
| Lipid → water-soluble conversion | Enables renal excretion |
| Detoxification of xenobiotics | Protects body from foreign chemicals |
| Drug inactivation | Terminates drug action |
| Prodrug activation | Converts inactive drug to active form |
| Termination of action | Controls duration of drug effect |
First pass effect
python3 -c " import pdfplumber path = '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' with pdfplumber.open(path) as pdf: for i, page in enumerate(pdf.pages): text = page.extract_text() if text and ('first pass' in text.lower() or 'first-pass' in text.lower() or 'bioavailab' in text.lower() or 'hepatic' in text.lower()): print(f'--- Page {i+1} ---') print(text[:800]) print() " 2>&1 | head -100
Drug given ORALLY
↓
Absorbed from stomach/small intestine
↓
Enters Portal Vein
↓
Passes through LIVER (first time)
↓
Liver enzymes (CYP450) metabolize a large fraction
↓
Only a REDUCED amount of active drug reaches
systemic circulation (inferior vena cava → heart → target organ)
| Site | Mechanism |
|---|---|
| Liver | Primary site - CYP450 enzymes (most important) |
| Gut wall (intestinal mucosa) | CYP3A4 enzymes in enterocytes metabolize drug before absorption |
| Lungs | Minor contribution for some drugs |
| Plasma | Esterases break down some drugs |
| Drug | First Pass Effect | Oral Bioavailability |
|---|---|---|
| Lidocaine | Very high | ~3% (not given orally) |
| Morphine | High | ~25-30% |
| Propranolol | High | ~25% |
| Nitroglycerin | Very high | ~1-2% (given sublingually) |
| Levodopa | High | Given with carbidopa to reduce peripheral conversion |
| Valacyclovir | Low | ~55% (better than acyclovir) |
| Method | Example |
|---|---|
| Sublingual route | Nitroglycerin - directly absorbed into systemic circulation under tongue |
| Buccal route | Drug absorbed through buccal mucosa, bypasses portal circulation |
| Intravenous (IV) route | Drug goes directly into blood - no gut/liver involvement |
| Transdermal (skin patch) | Absorbed through skin into systemic circulation directly |
| Rectal route | Lower rectal veins drain into systemic circulation (bypasses liver partially) |
| Inhalation route | Drug absorbed via lungs directly into pulmonary circulation |
| Increase oral dose | Give higher oral dose to compensate for metabolism |
| Use prodrug | Drug designed to survive first pass (e.g., enalapril → enalaprilat) |
| Point | Detail |
|---|---|
| Definition | Metabolism of drug before reaching systemic circulation |
| Main site | Liver (CYP450 enzymes) |
| Route most affected | Oral route |
| Routes that bypass it | IV, sublingual, transdermal, inhalation, rectal |
| Result | Reduced bioavailability |
| Clinical relevance | Oral dose > IV dose for same effect |
| Veterinary relevance | Species differences in liver metabolism affect dosing |
Clinical use of immuno stimulants
python3 -c " import pdfplumber path = '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' with pdfplumber.open(path) as pdf: for i, page in enumerate(pdf.pages): text = page.extract_text() if text and ('immunostimul' in text.lower() or 'immuno-stimul' in text.lower() or 'immune stimul' in text.lower() or 'immunomodulat' in text.lower() or 'interferon' in text.lower() or 'interleukin' in text.lower() or 'colony stimulat' in text.lower()): print(f'--- Page {i+1} ---') print(text[:900]) print() " 2>&1 | head -150
| Type | Produced By | Clinical Uses |
|---|---|---|
| Interferon-α | Leukocytes | Cancer: Kaposi's sarcoma, melanoma, hairy cell leukemia; Chronic Hepatitis B & C |
| Interferon-β | Fibroblasts | Multiple sclerosis (reduces frequency of exacerbations) |
| Interferon-γ | CD4+ T cells | Chronic granulomatous disease |
| Drug | Clinical Uses |
|---|---|
| Lenalidomide | Multiple myeloma, select lymphomas, myelodysplastic syndrome |
| Thalidomide | Multiple myeloma, erythema nodosum leprosum (ENL) |
| Drug | Source | Use |
|---|---|---|
| Echinacea | Purple coneflower | Stimulates macrophage activity, used in dogs/cats for recurrent infections |
| Acemannan | Aloe vera | Used in cats/dogs - fibrosarcoma adjunct therapy, wound healing |
| Propolis | Bees | Antimicrobial + immunostimulant in poultry |
| Immunostimulant | Key Clinical Use |
|---|---|
| Interferon-α | Hepatitis B/C, Kaposi's sarcoma, hairy cell leukemia |
| Interferon-β | Multiple sclerosis |
| Interferon-γ | Chronic granulomatous disease |
| EPO | Anemia (renal failure, chemo) |
| G-CSF | Chemotherapy-induced neutropenia |
| Lenalidomide | Multiple myeloma |
| Thalidomide | Multiple myeloma, ENL (leprosy) |
| Levamisole | Immunodeficiency, cancer adjunct, dewormer |
| BCG | TB vaccine, bladder cancer |
| IL-2 | Renal cell carcinoma, melanoma |
| Vaccines | Prevention of infectious diseases |
Gene therapy
python3 -c " import pdfplumber path = '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' with pdfplumber.open(path) as pdf: for i, page in enumerate(pdf.pages): text = page.extract_text() if text and ('gene therapy' in text.lower() or 'gene transfer' in text.lower() or 'vector' in text.lower() or 'retrovir' in text.lower() or 'antisense' in text.lower()): print(f'--- Page {i+1} ---') print(text[:900]) print() " 2>&1 | head -120
Normal/therapeutic gene
↓
Packaged into a VECTOR (delivery vehicle)
↓
Introduced into TARGET CELLS (in vivo or ex vivo)
↓
Gene integrates or functions within the cell
↓
Produces therapeutic protein / corrects defect
↓
Disease is treated or prevented
| Type | Target | Description |
|---|---|---|
| Somatic gene therapy | Body (somatic) cells | Changes affect only the treated individual; most common and ethically accepted |
| Germline gene therapy | Egg/sperm cells | Changes pass to offspring; ethically controversial, not approved for humans |
| Approach | Description | Example |
|---|---|---|
| Gene replacement | Replace a faulty/mutated gene with a normal copy | Cystic fibrosis (CFTR gene) |
| Gene addition | Add a new functional gene to compensate for defect | Hemophilia A (Factor VIII gene) |
| Gene silencing | Switch off a harmful/overactive gene using antisense or RNAi | Cancer oncogenes |
| Gene editing | Precise correction of mutations using tools like CRISPR-Cas9 | Sickle cell disease |
| Vector | Features | Uses |
|---|---|---|
| Retrovirus | Integrates into host genome; affects dividing cells only; risk of insertional mutagenesis | Cancer gene therapy, SCID |
| Lentivirus | Integrates into genome; infects both dividing and non-dividing cells; derived from HIV | Blood disorders, HIV therapy |
| Adenovirus | Does NOT integrate; high efficiency; causes immune reaction; transient expression | Cystic fibrosis, cancer |
| Adeno-Associated Virus (AAV) | Does not integrate (mostly); low immunogenicity; long-lasting; most preferred currently | Hemophilia, muscular dystrophy, retinal disease |
| Herpes simplex virus | Infects neurons; large gene capacity | Neurological diseases |
| Vector | Description |
|---|---|
| Liposomes | Lipid vesicles carrying DNA; fuse with cell membrane |
| Naked DNA | Direct injection of plasmid DNA into tissue |
| Gene gun (biolistics) | DNA coated on gold particles shot into cells |
| Electroporation | Electric pulse creates pores in membrane for DNA entry |
| Nanoparticles | Polymer/lipid nanoparticles (basis of mRNA COVID-19 vaccines) |
| Route | Method |
|---|---|
| In vivo | Vector directly injected into patient's body (IV, intramuscular, intra-organ) |
| Ex vivo | Cells removed from patient → gene inserted in lab → cells reinfused back |
| In situ | Vector delivered directly to the site of disease (e.g., into tumor) |
| Disease | Gene/Approach |
|---|---|
| Severe Combined Immunodeficiency (SCID) | ADA gene replacement (first successful gene therapy case) |
| Hemophilia A & B | Factor VIII / Factor IX gene delivery |
| Cystic fibrosis | CFTR gene delivery to lung epithelium |
| Sickle cell disease | Beta-globin gene correction (CRISPR) |
| Retinal dystrophy (Leber's) | RPE65 gene via AAV - first FDA-approved gene therapy (Luxturna) |
| Spinal muscular atrophy (SMA) | SMN1 gene via AAV (Zolgensma) |
| Cancer | Suicide gene therapy, tumor suppressor gene delivery, CAR-T cell therapy |
| Duchenne muscular dystrophy | Dystrophin gene |
| Parkinson's disease | AADC enzyme gene delivery |
| Application | Species |
|---|---|
| Canine muscular dystrophy | Dogs (golden retriever model) |
| Retinal degeneration | Dogs, cats |
| Hemophilia | Dogs (canine Factor IX) |
| Cancer immunotherapy | Dogs, cats |
| FIV/FeLV treatment | Cats |
| Vaccination | DNA vaccines in fish, poultry (viral diseases) |
| Production animals | Improved disease resistance, productivity traits |
| Problem | Explanation |
|---|---|
| Immune reaction | Body may attack viral vector or transfected cells |
| Insertional mutagenesis | Retroviral DNA may insert near oncogenes → cancer risk |
| Short duration of effect | Non-integrating vectors lose gene over time |
| Delivery difficulty | Hard to reach all target cells efficiently |
| High cost | Gene therapy products are extremely expensive |
| Ethical issues | Germline editing raises ethical and social concerns |
| Off-target effects | CRISPR may edit unintended genome sites |
| Point | Key Fact |
|---|---|
| Definition | Introduction/correction of genetic material for therapeutic purposes |
| Most used vector | AAV (Adeno-Associated Virus) |
| First approved gene therapy | Luxturna (retinal dystrophy, 2017 - FDA) |
| First gene therapy success | ADA-SCID (1990) |
| Most precise editing tool | CRISPR-Cas9 |
| Main veterinary use | Canine muscular dystrophy, retinal diseases, cancer |
| Major risk of retrovirus | Insertional mutagenesis (cancer risk) |
| Ex vivo vs In vivo | Ex vivo = cells removed & modified; In vivo = direct delivery |
Therapeutic use of vitamin k
python3 -c " import pdfplumber path = '/tmp/workspace/attachments/01f7878f-d86f-473c-a88e-58e8ac38a7aa/Pharmacology Flashcards by Baron and Lee.pdf' with pdfplumber.open(path) as pdf: for i, page in enumerate(pdf.pages): text = page.extract_text() if text and ('vitamin k' in text.lower() or 'vit k' in text.lower() or 'phytomenadione' in text.lower() or 'phytonadione' in text.lower() or 'menadione' in text.lower() or 'coagulation factor' in text.lower() or 'warfarin' in text.lower()): print(f'--- Page {i+1} ---') print(text[:900]) print() " 2>&1 | head -150
Create a study guide document on pharmacokinetics for revision
Therapeutic use of vit k
Now i will ask question covering around 4 to 6 marks